RARRES2 and polycystic ovary syndrome: Patients with polycystic ovary syndrome (PCOS) exhibit significantly elevated serum chemerin levels and increased chemerin expression in ovarian tissue [80], linking it to inflammatory and metabolic disturbances characteristic of this condition.